Chan J - Search Results

1

New lymph node staging for rectal neuroendocrine tumors.

Fields AC, McCarty JC, Ma-Pak L, Lu P, Irani J, Goldberg JE, Bleday R, Chan J, Melnitchouk N. Fields AC, et al. Among authors: chan j. J Surg Oncol. 2019 Jan;119(1):156-162. doi: 10.1002/jso.25307. Epub 2018 Nov 27. J Surg Oncol. 2019. PMID: 30481376

2

Progress in the treatment of neuroendocrine tumors.

Chan JA, Kulke MH. Chan JA, et al. Curr Oncol Rep. 2009 May;11(3):193-9. doi: 10.1007/s11912-009-0028-0. Curr Oncol Rep. 2009. PMID: 19336011 Free PMC article. Review.

3

Phase II study of pemetrexed in patients with advanced neuroendocrine tumors.

Chan JA, Zhu AX, Stuart K, Bhargava P, Earle CC, Clark JW, Casey C, Regan E, Kulke MH. Chan JA, et al. Cancer Chemother Pharmacol. 2010 Oct;66(5):961-8. doi: 10.1007/s00280-010-1248-6. Epub 2010 Feb 4. Cancer Chemother Pharmacol. 2010. PMID: 20130879 Free PMC article. Clinical Trial.

4

New treatment options for patients with advanced neuroendocrine tumors.

Chan JA, Kulke MH. Chan JA, et al. Curr Treat Options Oncol. 2011 Jun;12(2):136-48. doi: 10.1007/s11864-011-0148-2. Curr Treat Options Oncol. 2011. PMID: 21437592 Review.

5

Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors.

Chan JA, Stuart K, Earle CC, Clark JW, Bhargava P, Miksad R, Blaszkowsky L, Enzinger PC, Meyerhardt JA, Zheng H, Fuchs CS, Kulke MH. Chan JA, et al. J Clin Oncol. 2012 Aug 20;30(24):2963-8. doi: 10.1200/JCO.2011.40.3147. Epub 2012 Jul 9. J Clin Oncol. 2012. PMID: 22778320 Free PMC article. Clinical Trial.

6

Prognostic significance of MTOR pathway component expression in neuroendocrine tumors.

Qian ZR, Ter-Minassian M, Chan JA, Imamura Y, Hooshmand SM, Kuchiba A, Morikawa T, Brais LK, Daskalova A, Heafield R, Lin X, Christiani DC, Fuchs CS, Ogino S, Kulke MH. Qian ZR, et al. J Clin Oncol. 2013 Sep 20;31(27):3418-25. doi: 10.1200/JCO.2012.46.6946. Epub 2013 Aug 26. J Clin Oncol. 2013. PMID: 23980085 Free PMC article.

7

Targeting the mTOR signaling pathway in neuroendocrine tumors.

Chan J, Kulke M. Chan J, et al. Curr Treat Options Oncol. 2014 Sep;15(3):365-79. doi: 10.1007/s11864-014-0294-4. Curr Treat Options Oncol. 2014. PMID: 25092520 Free PMC article. Review.

8

Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study.

Phan AT, Halperin DM, Chan JA, Fogelman DR, Hess KR, Malinowski P, Regan E, Ng CS, Yao JC, Kulke MH. Phan AT, et al. Lancet Oncol. 2015 Jun;16(6):695-703. doi: 10.1016/S1470-2045(15)70136-1. Epub 2015 May 5. Lancet Oncol. 2015. PMID: 25956795 Free PMC article. Clinical Trial.

9

Neuroendocrine Tumors--Current and Future Clinical Advances.

Chan JA, Kulke MH. Chan JA, et al. Hematol Oncol Clin North Am. 2016 Feb;30(1):xiii-xiv. doi: 10.1016/j.hoc.2015.09.012. Epub 2015 Oct 20. Hematol Oncol Clin North Am. 2016. PMID: 26614379 No abstract available.

10

Medical Management of Pancreatic Neuroendocrine Tumors: Current and Future Therapy.

Chan JA, Kulke MH. Chan JA, et al. Surg Oncol Clin N Am. 2016 Apr;25(2):423-37. doi: 10.1016/j.soc.2015.11.009. Epub 2016 Feb 19. Surg Oncol Clin N Am. 2016. PMID: 27013373 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,024 results

Search Page

Filters